Structural and evolutionary analyses support reclassification of glycopeptide antibiotics as xyclopeptides
This study proposes reclassifying glycopeptide antibiotics into the broader class of xyclopeptides, subdivided into dalabactins (classical types I–IV) and murobactins (type V), based on structural and evolutionary analyses that reveal a fundamental divergence between these two groups.